213 related articles for article (PubMed ID: 26246330)
1. Incidence of adverse cutaneous drug reactions in 22,866 Chinese inpatients: a prospective study.
Tian XY; Liu B; Shi H; Zhao ZR; Zhou XP; Zhang T; Sun QN; Zuo YG
Arch Dermatol Res; 2015 Nov; 307(9):829-34. PubMed ID: 26246330
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
Ding WY; Lee CK; Choon SE
Int J Dermatol; 2010 Jul; 49(7):834-41. PubMed ID: 20618508
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous adverse drug reactions in a hospital-based Chinese population.
Huang HY; Luo XQ; Chan LS; Cao ZH; Sun XF; Xu JH
Clin Exp Dermatol; 2011 Mar; 36(2):135-41. PubMed ID: 20738322
[TBL] [Abstract][Full Text] [Related]
4. A cross-sectional study of cutaneous drug reactions in a private dental college and government medical college in eastern India.
Chattopadhyay C; Chakrabarti N
Niger J Clin Pract; 2012; 15(2):194-8. PubMed ID: 22718172
[TBL] [Abstract][Full Text] [Related]
5. Impact of pharmacovigilance on adverse drug reactions reporting in hospitalized internal medicine patients at Saudi Arabian teaching hospital.
Khan LM; Al-Harthi SE; Saadah OI; Al-Amoudi AB; Sulaiman MI; Ibrahim IM
Saudi Med J; 2012 Aug; 33(8):863-8. PubMed ID: 22886119
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous adverse drug reactions: clinical pattern and causative agents--a 6 year series from Chandigarh, India.
Sharma VK; Sethuraman G; Kumar B
J Postgrad Med; 2001; 47(2):95-9. PubMed ID: 11832597
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous adverse drug reactions: a 9-year study from a South Indian Hospital.
Sushma M; Noel MV; Ritika MC; James J; Guido S
Pharmacoepidemiol Drug Saf; 2005 Aug; 14(8):567-70. PubMed ID: 15937869
[TBL] [Abstract][Full Text] [Related]
8. A 6-month prospective survey of cutaneous drug reactions in a hospital setting.
Fiszenson-Albala F; Auzerie V; Mahe E; Farinotti R; Durand-Stocco C; Crickx B; Descamps V
Br J Dermatol; 2003 Nov; 149(5):1018-22. PubMed ID: 14632808
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous adverse drug reactions seen at a university hospital department of dermatology.
Borch JE; Andersen KE; Bindslev-Jensen C
Acta Derm Venereol; 2006; 86(6):523-7. PubMed ID: 17106600
[TBL] [Abstract][Full Text] [Related]
10. [Retrospective analysis of adverse cutaneous drug reactions in patients hospitalized in Department of Dermatology and Venereology of Pomeranian Medical University in 1996-2006].
Kacalak-Rzepka A; Klimowicz A; Bielecka-Grzela S; Załuga E; Maleszka R; Fabiańczyk H
Ann Acad Med Stetin; 2008; 54(2):52-8. PubMed ID: 19374232
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological study of severe cutaneous adverse drug reactions in a city district of China.
Li LF; Ma C
Clin Exp Dermatol; 2006 Sep; 31(5):642-7. PubMed ID: 16901302
[TBL] [Abstract][Full Text] [Related]
12. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
Jose J; Rao PG
Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous reactions to proton pump inhibitors: a case-control study.
Chularojanamontri L; Jiamton S; Manapajon A; Suvanasuthi S; Kulthanan K; Dhana N; Jongjarearnprasert K
J Drugs Dermatol; 2012 Oct; 11(10):e43-7. PubMed ID: 23134998
[TBL] [Abstract][Full Text] [Related]
14. Adverse cutaneous drug reactions--a clinico-demographic study in a tertiary care teaching hospital of the Kashmir Valley, India.
Qayoom S; Bisati S; Manzoor S; Sameem F; Khan K
Arch Iran Med; 2015 Apr; 18(4):228-33. PubMed ID: 25841943
[TBL] [Abstract][Full Text] [Related]
15. Risk factors of adverse drug reaction from non-steroidal anti-inflammatory drugs in Shanghai patients with arthropathy.
Shi W; Wang YM; Li SL; Yan M; Li D; Chen BY; Cheng NN
Acta Pharmacol Sin; 2004 Mar; 25(3):357-65. PubMed ID: 15000891
[TBL] [Abstract][Full Text] [Related]
16. Drug-related mortality among inpatients: a retrospective observational study.
Pardo Cabello AJ; Del Pozo Gavilán E; Gómez Jiménez FJ; Mota Rodríguez C; Luna Del Castillo Jde D; Puche Cañas E
Eur J Clin Pharmacol; 2016 Jun; 72(6):731-6. PubMed ID: 26896941
[TBL] [Abstract][Full Text] [Related]
17. Causative drugs for drug-induced cutaneous reactions in central China: a 608-case analysis.
Zhao J; Hu L; Zhang L; Zhou M; Gao L; Cheng L
An Bras Dermatol; 2019; 94(6):664-670. PubMed ID: 31789251
[TBL] [Abstract][Full Text] [Related]
18. Clinical profile of cutaneous adverse drug reactions: a retrospective study of 1883 hospitalized patients from 2007 to 2016 in Shanghai, China.
Yang F; Chen Z; Chen SA; Zhu Q; Wang L; Xiong H; Fu H; Luo X
Eur J Dermatol; 2020 Feb; 30(1):24-31. PubMed ID: 32031529
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive 4-year survey of adverse drug reactions using a network-based hospital system.
Chen CJ; Cheng CF; Lin HY; Hung SP; Chen WC; Lin MS
J Clin Pharm Ther; 2012 Dec; 37(6):647-51. PubMed ID: 22646235
[TBL] [Abstract][Full Text] [Related]
20. An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
Choon SE; Lai NM
Indian J Dermatol Venereol Leprol; 2012; 78(6):734-9. PubMed ID: 23075643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
